Last reviewed · How we verify
NCT06339671: PASSAGE
Post-operative Complications and Smoking Habits in Colorectal Surgery
trial in Colorectal Disorders in 1,527 participants. Currently enrolling.
25 September 2025
Quick facts
| Lead sponsor | IRCCS Ospedale San Raffaele |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,527 |
| Start date | 15 April 2024 |
| Primary completion | 25 September 2025 |
| Estimated completion | 25 September 2025 |
| Sites | 1 location across Italy |
Conditions studied
- Colorectal Disorders — all drugs for Colorectal Disorders →
Sponsor
IRCCS Ospedale San Raffaele — full company profile →
Who can join
18 and older, any sex, with Colorectal Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
PASSAGE is a national multicenter retrospective and prospective observational cohort study in which patients who will undergo colorectal surgery will be enrolled.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06339671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Disorders
Currently open trials in the same condition.
- NCT06657924 — Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery · Phase 2 · recruiting
- NCT06430931 — Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery · NA · recruiting
- NCT05005117 — Laparoscopic Approach for Emergency Colon Resection · NA · recruiting
- NCT06342440 — Early Detection of Advanced Adenomas and Colorectal Cancer · recruiting
Other IRCCS Ospedale San Raffaele trials
Trials by the same sponsor.
- NCT07530107 — Observational, Retrospective, Single-center Study Aimed at Evaluating Long-term Outcomes Following Transvenous Lead Extr · not yet recruiting
- NCT07171905 — CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease · Phase 2 · recruiting
- NCT07275099 — Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome. · not yet recruiting
- NCT06896305 — Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Rando · NA · recruiting
- NCT06667128 — Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart F · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06339671 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Ospedale San Raffaele
- Last refreshed: 24 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06339671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing